Skip to main content

CNS Demyelinating Disease Evaluation Profile, Serum

CPT 86052; 86362
Synonyms
  • CNS Demyelinating Panel

Test Details

Methodology

Cell-based Immunofluorescence (IFA)

Result Turnaround Time

5 Days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

This test is beneficial for the initial assessment of inflammatory diseases involving demyelination in the central nervous system (CNS), which includes conditions like neuromyelitis optica spectrum disorder (NMOSD) and NMOSD-like disorders, as well as acute disseminated encephalomyelitiis (ADEM).

Limitations

Results of this profile should be used in conjunction with clinical findings and other laboratory tests.

Custom Additional Information

Neuromyelitis optica spectrum disorders (NMOSDs), classified as immune-mediated chronic and frequently recurring inflammatory conditions, primarily impact the optic nerve and spinal cord. While NMOSDs can occur in any demographic, they tend to be more prevalent in middle-aged and elderly women. Due to the presence of similar symptoms such as optic neuritis and transverse myelitis, NMOSDs are sometimes misdiagnosed as multiple sclerosis (MS). However, distinguishing factors between the two conditions include the clinical progression, the location and size of lesions in the brain and/or spinal cord, the occurence of optic neuritis, and the detection of specific autoantibodies like aquaporin-4 receptor (AQP4) or myelin oligodendrocyte glycoprotein (MOG) IgG. Once initial non-specific tests have been conducted to exclude infections, vasculitis and other conditions that may resemble NMOSDs in their presentation, it is recommended to assess the serum antibody status for AQP4 IgG and MOG IgG. The detection of AQP4 IgG antibodies in the appropriated clinical context confirms the presence of NMOSDs. In patients with MS, AQP4 IgG testing generally yields negative results, whereas around 75% of NMOSD patients show antibodies targeting the AQP4 receptor. Although a small percentage of individuals with clinical symptoms suggestive of NMOSDs may test negative for AQP4 IgG, they may still have detectable serum MOG IgG antibodies. It is important to note that the absence of both AQP4 IgG and MOG IgG antibodies does not exclude the diagnosis of NMOSD, and it is advisable to consider retesting before initiating antibody-targeted therapies.

Specimen Requirements

Specimen

Serum

Volume

2 mL

Minimum Volume

1 mL

Container

Gel-barrier tube, red-top tube, serum transfer tube

Collection Instructions

Specimen should be free of bacterial contamination, hemolysis and lipemia.

Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/thaw cycles

Stable x3

Storage Instructions

Room temperature

Causes for Rejection

Hemolysis; lipemia; heat-treated specimen; gross bacterial contamination

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
505485 CNS Demyelinating Disease REQUEST 505296 AQP4 Antibody, Cell-based IFA 63439-4
505485 CNS Demyelinating Disease REQUEST 505311 MOG Antibody, Cell-based IFA 91545-4
Order Code505485
Order Code NameCNS Demyelinating Disease
Order LoincREQUEST
Result Code505296
Result Code NameAQP4 Antibody, Cell-based IFA
UofM
Result LOINC63439-4
Order Code505485
Order Code NameCNS Demyelinating Disease
Order LoincREQUEST
Result Code505311
Result Code NameMOG Antibody, Cell-based IFA
UofM
Result LOINC91545-4
Reflex Table for AQP4 Antibody, Cell-based IFA
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 505298 Anti-AQP4 Antibody, Titer 505298 Anti-AQP4 Antibody, Titer 68548-7
Reflex 1
Order Code505298
Order NameAnti-AQP4 Antibody, Titer
Result Code505298
Result NameAnti-AQP4 Antibody, Titer
UofM
Result LOINC68548-7
Reflex Table for MOG Antibody, Cell-based IFA
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 505312 Anti-MOG Antibody Titer, Serum 505312 Anti-MOG Antibody Titer, Serum 91544-7
Reflex 1
Order Code505312
Order NameAnti-MOG Antibody Titer, Serum
Result Code505312
Result NameAnti-MOG Antibody Titer, Serum
UofM
Result LOINC91544-7